nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—BCHE—epilepsy syndrome	0.155	0.515	CbGaD
Mefloquine—ADORA1—Gabapentin—epilepsy syndrome	0.152	0.423	CbGbCtD
Mefloquine—CYP2D6—epilepsy syndrome	0.0848	0.283	CbGaD
Mefloquine—ABCB1—epilepsy syndrome	0.0606	0.202	CbGaD
Mefloquine—ABCB1—Levetiracetam—epilepsy syndrome	0.0181	0.0502	CbGbCtD
Mefloquine—ABCB1—Clobazam—epilepsy syndrome	0.0125	0.0348	CbGbCtD
Mefloquine—ABCB1—Lamotrigine—epilepsy syndrome	0.0121	0.0335	CbGbCtD
Mefloquine—ABCB1—Carbamazepine—epilepsy syndrome	0.0104	0.0289	CbGbCtD
Mefloquine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0099	0.0275	CbGbCtD
Mefloquine—ABCB1—Phenytoin—epilepsy syndrome	0.00931	0.0259	CbGbCtD
Mefloquine—CYP3A4—Trimethadione—epilepsy syndrome	0.00921	0.0256	CbGbCtD
Mefloquine—CYP3A4—Felbamate—epilepsy syndrome	0.00921	0.0256	CbGbCtD
Mefloquine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00865	0.0241	CbGbCtD
Mefloquine—ABCB1—Phenobarbital—epilepsy syndrome	0.0083	0.0231	CbGbCtD
Mefloquine—ABCB1—Midazolam—epilepsy syndrome	0.00818	0.0227	CbGbCtD
Mefloquine—CYP2D6—Propofol—epilepsy syndrome	0.00818	0.0227	CbGbCtD
Mefloquine—ABCB1—Diazepam—epilepsy syndrome	0.00786	0.0219	CbGbCtD
Mefloquine—CYP3A4—Clonazepam—epilepsy syndrome	0.00783	0.0218	CbGbCtD
Mefloquine—HBA1—forelimb—epilepsy syndrome	0.00755	0.133	CbGeAlD
Mefloquine—CYP3A4—Clobazam—epilepsy syndrome	0.0075	0.0209	CbGbCtD
Mefloquine—HBA2—forelimb—epilepsy syndrome	0.00693	0.122	CbGeAlD
Mefloquine—CYP3A4—Rufinamide—epilepsy syndrome	0.00638	0.0177	CbGbCtD
Mefloquine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00622	0.0173	CbGbCtD
Mefloquine—CYP3A4—Primidone—epilepsy syndrome	0.0058	0.0161	CbGbCtD
Mefloquine—CYP3A4—Phenytoin—epilepsy syndrome	0.00558	0.0155	CbGbCtD
Mefloquine—CYP3A4—Propofol—epilepsy syndrome	0.0052	0.0145	CbGbCtD
Mefloquine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00497	0.0138	CbGbCtD
Mefloquine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00497	0.0138	CbGbCtD
Mefloquine—CYP3A4—Midazolam—epilepsy syndrome	0.0049	0.0136	CbGbCtD
Mefloquine—CYP3A4—Diazepam—epilepsy syndrome	0.00471	0.0131	CbGbCtD
Mefloquine—CYP3A4—Zonisamide—epilepsy syndrome	0.0046	0.0128	CbGbCtD
Mefloquine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00371	0.0103	CbGbCtD
Mefloquine—Flecainide—SCN4A—epilepsy syndrome	0.00364	0.855	CrCbGaD
Mefloquine—CYP3A4—Topiramate—epilepsy syndrome	0.00335	0.00932	CbGbCtD
Mefloquine—HBA1—hindbrain—epilepsy syndrome	0.00309	0.0543	CbGeAlD
Mefloquine—ADORA2A—ganglion—epilepsy syndrome	0.00195	0.0342	CbGeAlD
Mefloquine—HBA1—brainstem—epilepsy syndrome	0.00177	0.0311	CbGeAlD
Mefloquine—HBA1—forebrain—epilepsy syndrome	0.00171	0.0301	CbGeAlD
Mefloquine—ADORA1—ganglion—epilepsy syndrome	0.00168	0.0296	CbGeAlD
Mefloquine—HBA1—telencephalon—epilepsy syndrome	0.00157	0.0276	CbGeAlD
Mefloquine—HBA2—forebrain—epilepsy syndrome	0.00157	0.0276	CbGeAlD
Mefloquine—HBA1—spinal cord—epilepsy syndrome	0.0011	0.0194	CbGeAlD
Mefloquine—HBA2—spinal cord—epilepsy syndrome	0.00101	0.0178	CbGeAlD
Mefloquine—HBA1—head—epilepsy syndrome	0.00098	0.0172	CbGeAlD
Mefloquine—HBA1—nervous system—epilepsy syndrome	0.000929	0.0163	CbGeAlD
Mefloquine—HBA2—head—epilepsy syndrome	0.0009	0.0158	CbGeAlD
Mefloquine—HBA1—central nervous system—epilepsy syndrome	0.000895	0.0157	CbGeAlD
Mefloquine—HBA1—cerebellum—epilepsy syndrome	0.000875	0.0154	CbGeAlD
Mefloquine—HBA2—nervous system—epilepsy syndrome	0.000853	0.015	CbGeAlD
Mefloquine—HBA2—central nervous system—epilepsy syndrome	0.000821	0.0144	CbGeAlD
Mefloquine—ADORA2A—forebrain—epilepsy syndrome	0.000818	0.0144	CbGeAlD
Mefloquine—HBA2—cerebellum—epilepsy syndrome	0.000803	0.0141	CbGeAlD
Mefloquine—ADORA2A—telencephalon—epilepsy syndrome	0.000752	0.0132	CbGeAlD
Mefloquine—HBA1—brain—epilepsy syndrome	0.00071	0.0125	CbGeAlD
Mefloquine—ADORA1—forebrain—epilepsy syndrome	0.000706	0.0124	CbGeAlD
Mefloquine—HBA2—brain—epilepsy syndrome	0.000652	0.0115	CbGeAlD
Mefloquine—ADORA1—telencephalon—epilepsy syndrome	0.00065	0.0114	CbGeAlD
Mefloquine—ACHE—telencephalon—epilepsy syndrome	0.000646	0.0113	CbGeAlD
Mefloquine—Flecainide—CYP2D6—epilepsy syndrome	0.00062	0.145	CrCbGaD
Mefloquine—ADORA2A—spinal cord—epilepsy syndrome	0.000527	0.00926	CbGeAlD
Mefloquine—ADORA1—medulla oblongata—epilepsy syndrome	0.00051	0.00896	CbGeAlD
Mefloquine—ACHE—medulla oblongata—epilepsy syndrome	0.000507	0.00891	CbGeAlD
Mefloquine—CYP19A1—forebrain—epilepsy syndrome	0.000479	0.00841	CbGeAlD
Mefloquine—ADORA2A—head—epilepsy syndrome	0.000468	0.00823	CbGeAlD
Mefloquine—ADORA1—midbrain—epilepsy syndrome	0.000466	0.00819	CbGeAlD
Mefloquine—ACHE—midbrain—epilepsy syndrome	0.000464	0.00814	CbGeAlD
Mefloquine—ADORA1—spinal cord—epilepsy syndrome	0.000455	0.00799	CbGeAlD
Mefloquine—ACHE—spinal cord—epilepsy syndrome	0.000452	0.00794	CbGeAlD
Mefloquine—ADORA2A—nervous system—epilepsy syndrome	0.000444	0.0078	CbGeAlD
Mefloquine—ADORA2A—central nervous system—epilepsy syndrome	0.000428	0.00751	CbGeAlD
Mefloquine—ADORA2A—cerebellum—epilepsy syndrome	0.000418	0.00734	CbGeAlD
Mefloquine—CYP2D6—hindbrain—epilepsy syndrome	0.000413	0.00726	CbGeAlD
Mefloquine—ADORA1—head—epilepsy syndrome	0.000404	0.0071	CbGeAlD
Mefloquine—ADORA1—nervous system—epilepsy syndrome	0.000383	0.00673	CbGeAlD
Mefloquine—ADORA1—central nervous system—epilepsy syndrome	0.000369	0.00648	CbGeAlD
Mefloquine—ADORA1—cerebellum—epilepsy syndrome	0.000361	0.00634	CbGeAlD
Mefloquine—ACHE—cerebellum—epilepsy syndrome	0.000359	0.0063	CbGeAlD
Mefloquine—BCHE—brainstem—epilepsy syndrome	0.000358	0.00628	CbGeAlD
Mefloquine—BCHE—forebrain—epilepsy syndrome	0.000345	0.00606	CbGeAlD
Mefloquine—ADORA2A—brain—epilepsy syndrome	0.000339	0.00596	CbGeAlD
Mefloquine—BCHE—telencephalon—epilepsy syndrome	0.000317	0.00557	CbGeAlD
Mefloquine—ADORA1—brain—epilepsy syndrome	0.000293	0.00515	CbGeAlD
Mefloquine—ACHE—brain—epilepsy syndrome	0.000291	0.00511	CbGeAlD
Mefloquine—CYP19A1—head—epilepsy syndrome	0.000274	0.00482	CbGeAlD
Mefloquine—CYP19A1—nervous system—epilepsy syndrome	0.00026	0.00457	CbGeAlD
Mefloquine—CYP19A1—central nervous system—epilepsy syndrome	0.00025	0.0044	CbGeAlD
Mefloquine—BCHE—medulla oblongata—epilepsy syndrome	0.000249	0.00438	CbGeAlD
Mefloquine—CYP2D6—brainstem—epilepsy syndrome	0.000237	0.00416	CbGeAlD
Mefloquine—CYP2D6—forebrain—epilepsy syndrome	0.000229	0.00401	CbGeAlD
Mefloquine—BCHE—midbrain—epilepsy syndrome	0.000228	0.004	CbGeAlD
Mefloquine—BCHE—spinal cord—epilepsy syndrome	0.000222	0.0039	CbGeAlD
Mefloquine—CYP2D6—telencephalon—epilepsy syndrome	0.00021	0.00369	CbGeAlD
Mefloquine—CYP19A1—brain—epilepsy syndrome	0.000199	0.00349	CbGeAlD
Mefloquine—BCHE—head—epilepsy syndrome	0.000198	0.00347	CbGeAlD
Mefloquine—BCHE—nervous system—epilepsy syndrome	0.000187	0.00329	CbGeAlD
Mefloquine—BCHE—central nervous system—epilepsy syndrome	0.00018	0.00317	CbGeAlD
Mefloquine—BCHE—cerebellum—epilepsy syndrome	0.000176	0.00309	CbGeAlD
Mefloquine—ABCB1—forebrain—epilepsy syndrome	0.000164	0.00289	CbGeAlD
Mefloquine—ABCB1—telencephalon—epilepsy syndrome	0.000151	0.00265	CbGeAlD
Mefloquine—BCHE—brain—epilepsy syndrome	0.000143	0.00251	CbGeAlD
Mefloquine—CYP2D6—head—epilepsy syndrome	0.000131	0.0023	CbGeAlD
Mefloquine—CYP3A4—nervous system—epilepsy syndrome	0.000126	0.00221	CbGeAlD
Mefloquine—CYP2D6—nervous system—epilepsy syndrome	0.000124	0.00218	CbGeAlD
Mefloquine—CYP3A4—central nervous system—epilepsy syndrome	0.000121	0.00213	CbGeAlD
Mefloquine—CYP2D6—central nervous system—epilepsy syndrome	0.000119	0.0021	CbGeAlD
Mefloquine—ABCB1—medulla oblongata—epilepsy syndrome	0.000119	0.00209	CbGeAlD
Mefloquine—CYP2D6—cerebellum—epilepsy syndrome	0.000117	0.00205	CbGeAlD
Mefloquine—ABCB1—midbrain—epilepsy syndrome	0.000109	0.00191	CbGeAlD
Mefloquine—ABCB1—spinal cord—epilepsy syndrome	0.000106	0.00186	CbGeAlD
Mefloquine—CYP2D6—brain—epilepsy syndrome	9.49e-05	0.00167	CbGeAlD
Mefloquine—ABCB1—head—epilepsy syndrome	9.42e-05	0.00165	CbGeAlD
Mefloquine—ABCB1—nervous system—epilepsy syndrome	8.93e-05	0.00157	CbGeAlD
Mefloquine—ABCB1—central nervous system—epilepsy syndrome	8.59e-05	0.00151	CbGeAlD
Mefloquine—ABCB1—cerebellum—epilepsy syndrome	8.4e-05	0.00147	CbGeAlD
Mefloquine—ABCB1—brain—epilepsy syndrome	6.82e-05	0.0012	CbGeAlD
Mefloquine—Pruritus—Phenytoin—epilepsy syndrome	4.62e-05	0.000263	CcSEcCtD
Mefloquine—Connective tissue disorder—Topiramate—epilepsy syndrome	4.62e-05	0.000262	CcSEcCtD
Mefloquine—Nausea—Levetiracetam—epilepsy syndrome	4.61e-05	0.000262	CcSEcCtD
Mefloquine—Rash—Vigabatrin—epilepsy syndrome	4.61e-05	0.000262	CcSEcCtD
Mefloquine—Dizziness—Felbamate—epilepsy syndrome	4.61e-05	0.000262	CcSEcCtD
Mefloquine—Dermatitis—Vigabatrin—epilepsy syndrome	4.6e-05	0.000262	CcSEcCtD
Mefloquine—Pruritus—Oxcarbazepine—epilepsy syndrome	4.59e-05	0.000261	CcSEcCtD
Mefloquine—Convulsion—Pregabalin—epilepsy syndrome	4.59e-05	0.000261	CcSEcCtD
Mefloquine—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.59e-05	0.000261	CcSEcCtD
Mefloquine—Vision blurred—Gabapentin—epilepsy syndrome	4.58e-05	0.00026	CcSEcCtD
Mefloquine—Headache—Vigabatrin—epilepsy syndrome	4.58e-05	0.00026	CcSEcCtD
Mefloquine—Hypertension—Pregabalin—epilepsy syndrome	4.58e-05	0.00026	CcSEcCtD
Mefloquine—Vomiting—Diazepam—epilepsy syndrome	4.58e-05	0.00026	CcSEcCtD
Mefloquine—Tremor—Gabapentin—epilepsy syndrome	4.55e-05	0.000259	CcSEcCtD
Mefloquine—Rash—Diazepam—epilepsy syndrome	4.54e-05	0.000258	CcSEcCtD
Mefloquine—Dermatitis—Diazepam—epilepsy syndrome	4.53e-05	0.000258	CcSEcCtD
Mefloquine—Visual impairment—Topiramate—epilepsy syndrome	4.53e-05	0.000257	CcSEcCtD
Mefloquine—Arthralgia—Pregabalin—epilepsy syndrome	4.51e-05	0.000257	CcSEcCtD
Mefloquine—Chest pain—Pregabalin—epilepsy syndrome	4.51e-05	0.000257	CcSEcCtD
Mefloquine—Myalgia—Pregabalin—epilepsy syndrome	4.51e-05	0.000257	CcSEcCtD
Mefloquine—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.51e-05	0.000256	CcSEcCtD
Mefloquine—Dizziness—Zonisamide—epilepsy syndrome	4.51e-05	0.000256	CcSEcCtD
Mefloquine—Headache—Diazepam—epilepsy syndrome	4.51e-05	0.000256	CcSEcCtD
Mefloquine—Anxiety—Pregabalin—epilepsy syndrome	4.5e-05	0.000256	CcSEcCtD
Mefloquine—Diarrhoea—Clonazepam—epilepsy syndrome	4.5e-05	0.000256	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.48e-05	0.000255	CcSEcCtD
Mefloquine—Hypotension—Valproic Acid—epilepsy syndrome	4.47e-05	0.000254	CcSEcCtD
Mefloquine—Asthenia—Carbamazepine—epilepsy syndrome	4.47e-05	0.000254	CcSEcCtD
Mefloquine—Agitation—Gabapentin—epilepsy syndrome	4.47e-05	0.000254	CcSEcCtD
Mefloquine—Diarrhoea—Phenytoin—epilepsy syndrome	4.47e-05	0.000254	CcSEcCtD
Mefloquine—Discomfort—Pregabalin—epilepsy syndrome	4.46e-05	0.000253	CcSEcCtD
Mefloquine—Nausea—Fosphenytoin—epilepsy syndrome	4.45e-05	0.000253	CcSEcCtD
Mefloquine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.44e-05	0.000253	CcSEcCtD
Mefloquine—Erythema multiforme—Topiramate—epilepsy syndrome	4.44e-05	0.000252	CcSEcCtD
Mefloquine—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.44e-05	0.000252	CcSEcCtD
Mefloquine—Vomiting—Felbamate—epilepsy syndrome	4.43e-05	0.000252	CcSEcCtD
Mefloquine—Pruritus—Carbamazepine—epilepsy syndrome	4.41e-05	0.000251	CcSEcCtD
Mefloquine—Rash—Felbamate—epilepsy syndrome	4.39e-05	0.00025	CcSEcCtD
Mefloquine—Eye disorder—Topiramate—epilepsy syndrome	4.39e-05	0.00025	CcSEcCtD
Mefloquine—Dermatitis—Felbamate—epilepsy syndrome	4.39e-05	0.000249	CcSEcCtD
Mefloquine—Malaise—Gabapentin—epilepsy syndrome	4.38e-05	0.000249	CcSEcCtD
Mefloquine—Tinnitus—Topiramate—epilepsy syndrome	4.38e-05	0.000249	CcSEcCtD
Mefloquine—Vertigo—Gabapentin—epilepsy syndrome	4.37e-05	0.000248	CcSEcCtD
Mefloquine—Headache—Felbamate—epilepsy syndrome	4.36e-05	0.000248	CcSEcCtD
Mefloquine—Confusional state—Pregabalin—epilepsy syndrome	4.36e-05	0.000248	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.36e-05	0.000248	CcSEcCtD
Mefloquine—Flushing—Topiramate—epilepsy syndrome	4.36e-05	0.000248	CcSEcCtD
Mefloquine—Cardiac disorder—Topiramate—epilepsy syndrome	4.36e-05	0.000248	CcSEcCtD
Mefloquine—Syncope—Gabapentin—epilepsy syndrome	4.36e-05	0.000248	CcSEcCtD
Mefloquine—Leukopenia—Gabapentin—epilepsy syndrome	4.35e-05	0.000247	CcSEcCtD
Mefloquine—Dizziness—Clonazepam—epilepsy syndrome	4.34e-05	0.000247	CcSEcCtD
Mefloquine—Nausea—Vigabatrin—epilepsy syndrome	4.34e-05	0.000247	CcSEcCtD
Mefloquine—Vomiting—Zonisamide—epilepsy syndrome	4.33e-05	0.000246	CcSEcCtD
Mefloquine—Insomnia—Valproic Acid—epilepsy syndrome	4.33e-05	0.000246	CcSEcCtD
Mefloquine—Oedema—Pregabalin—epilepsy syndrome	4.33e-05	0.000246	CcSEcCtD
Mefloquine—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.33e-05	0.000246	CcSEcCtD
Mefloquine—Asthenia—Lamotrigine—epilepsy syndrome	4.32e-05	0.000246	CcSEcCtD
Mefloquine—Dizziness—Phenytoin—epilepsy syndrome	4.32e-05	0.000245	CcSEcCtD
Mefloquine—Rash—Zonisamide—epilepsy syndrome	4.3e-05	0.000244	CcSEcCtD
Mefloquine—Paraesthesia—Valproic Acid—epilepsy syndrome	4.3e-05	0.000244	CcSEcCtD
Mefloquine—Palpitations—Gabapentin—epilepsy syndrome	4.29e-05	0.000244	CcSEcCtD
Mefloquine—Dermatitis—Zonisamide—epilepsy syndrome	4.29e-05	0.000244	CcSEcCtD
Mefloquine—Dizziness—Oxcarbazepine—epilepsy syndrome	4.29e-05	0.000244	CcSEcCtD
Mefloquine—Nausea—Diazepam—epilepsy syndrome	4.27e-05	0.000243	CcSEcCtD
Mefloquine—Loss of consciousness—Gabapentin—epilepsy syndrome	4.27e-05	0.000243	CcSEcCtD
Mefloquine—Headache—Zonisamide—epilepsy syndrome	4.27e-05	0.000243	CcSEcCtD
Mefloquine—Dyspnoea—Valproic Acid—epilepsy syndrome	4.27e-05	0.000243	CcSEcCtD
Mefloquine—Diarrhoea—Carbamazepine—epilepsy syndrome	4.26e-05	0.000242	CcSEcCtD
Mefloquine—Angiopathy—Topiramate—epilepsy syndrome	4.26e-05	0.000242	CcSEcCtD
Mefloquine—Pruritus—Lamotrigine—epilepsy syndrome	4.26e-05	0.000242	CcSEcCtD
Mefloquine—Shock—Pregabalin—epilepsy syndrome	4.26e-05	0.000242	CcSEcCtD
Mefloquine—Somnolence—Valproic Acid—epilepsy syndrome	4.25e-05	0.000242	CcSEcCtD
Mefloquine—Nervous system disorder—Pregabalin—epilepsy syndrome	4.24e-05	0.000241	CcSEcCtD
Mefloquine—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.23e-05	0.000241	CcSEcCtD
Mefloquine—Mediastinal disorder—Topiramate—epilepsy syndrome	4.23e-05	0.000241	CcSEcCtD
Mefloquine—Tachycardia—Pregabalin—epilepsy syndrome	4.22e-05	0.00024	CcSEcCtD
Mefloquine—Chills—Topiramate—epilepsy syndrome	4.21e-05	0.00024	CcSEcCtD
Mefloquine—Dyspepsia—Valproic Acid—epilepsy syndrome	4.21e-05	0.000239	CcSEcCtD
Mefloquine—Convulsion—Gabapentin—epilepsy syndrome	4.21e-05	0.000239	CcSEcCtD
Mefloquine—Skin disorder—Pregabalin—epilepsy syndrome	4.2e-05	0.000239	CcSEcCtD
Mefloquine—Hypertension—Gabapentin—epilepsy syndrome	4.2e-05	0.000239	CcSEcCtD
Mefloquine—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.18e-05	0.000238	CcSEcCtD
Mefloquine—Vomiting—Clonazepam—epilepsy syndrome	4.18e-05	0.000238	CcSEcCtD
Mefloquine—Decreased appetite—Valproic Acid—epilepsy syndrome	4.16e-05	0.000236	CcSEcCtD
Mefloquine—Alopecia—Topiramate—epilepsy syndrome	4.15e-05	0.000236	CcSEcCtD
Mefloquine—Vomiting—Phenytoin—epilepsy syndrome	4.15e-05	0.000236	CcSEcCtD
Mefloquine—Rash—Clonazepam—epilepsy syndrome	4.14e-05	0.000236	CcSEcCtD
Mefloquine—Dermatitis—Clonazepam—epilepsy syndrome	4.14e-05	0.000235	CcSEcCtD
Mefloquine—Myalgia—Gabapentin—epilepsy syndrome	4.14e-05	0.000235	CcSEcCtD
Mefloquine—Chest pain—Gabapentin—epilepsy syndrome	4.14e-05	0.000235	CcSEcCtD
Mefloquine—Arthralgia—Gabapentin—epilepsy syndrome	4.14e-05	0.000235	CcSEcCtD
Mefloquine—Nausea—Felbamate—epilepsy syndrome	4.14e-05	0.000235	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.13e-05	0.000235	CcSEcCtD
Mefloquine—Vomiting—Oxcarbazepine—epilepsy syndrome	4.13e-05	0.000235	CcSEcCtD
Mefloquine—Fatigue—Valproic Acid—epilepsy syndrome	4.12e-05	0.000235	CcSEcCtD
Mefloquine—Anxiety—Gabapentin—epilepsy syndrome	4.12e-05	0.000234	CcSEcCtD
Mefloquine—Dizziness—Carbamazepine—epilepsy syndrome	4.12e-05	0.000234	CcSEcCtD
Mefloquine—Diarrhoea—Lamotrigine—epilepsy syndrome	4.12e-05	0.000234	CcSEcCtD
Mefloquine—Headache—Clonazepam—epilepsy syndrome	4.12e-05	0.000234	CcSEcCtD
Mefloquine—Rash—Phenytoin—epilepsy syndrome	4.11e-05	0.000234	CcSEcCtD
Mefloquine—Mental disorder—Topiramate—epilepsy syndrome	4.11e-05	0.000234	CcSEcCtD
Mefloquine—Dermatitis—Phenytoin—epilepsy syndrome	4.11e-05	0.000234	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.11e-05	0.000234	CcSEcCtD
Mefloquine—Rash—Oxcarbazepine—epilepsy syndrome	4.09e-05	0.000233	CcSEcCtD
Mefloquine—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.09e-05	0.000233	CcSEcCtD
Mefloquine—Headache—Phenytoin—epilepsy syndrome	4.09e-05	0.000232	CcSEcCtD
Mefloquine—Erythema—Topiramate—epilepsy syndrome	4.09e-05	0.000232	CcSEcCtD
Mefloquine—Malnutrition—Topiramate—epilepsy syndrome	4.09e-05	0.000232	CcSEcCtD
Mefloquine—Discomfort—Gabapentin—epilepsy syndrome	4.09e-05	0.000232	CcSEcCtD
Mefloquine—Headache—Oxcarbazepine—epilepsy syndrome	4.07e-05	0.000231	CcSEcCtD
Mefloquine—Nausea—Zonisamide—epilepsy syndrome	4.05e-05	0.00023	CcSEcCtD
Mefloquine—Hypotension—Pregabalin—epilepsy syndrome	4.04e-05	0.00023	CcSEcCtD
Mefloquine—Confusional state—Gabapentin—epilepsy syndrome	4e-05	0.000227	CcSEcCtD
Mefloquine—Dizziness—Lamotrigine—epilepsy syndrome	3.98e-05	0.000226	CcSEcCtD
Mefloquine—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.97e-05	0.000226	CcSEcCtD
Mefloquine—Oedema—Gabapentin—epilepsy syndrome	3.97e-05	0.000226	CcSEcCtD
Mefloquine—Vomiting—Carbamazepine—epilepsy syndrome	3.96e-05	0.000225	CcSEcCtD
Mefloquine—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.94e-05	0.000224	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.94e-05	0.000224	CcSEcCtD
Mefloquine—Muscle spasms—Topiramate—epilepsy syndrome	3.93e-05	0.000223	CcSEcCtD
Mefloquine—Rash—Carbamazepine—epilepsy syndrome	3.93e-05	0.000223	CcSEcCtD
Mefloquine—Dermatitis—Carbamazepine—epilepsy syndrome	3.92e-05	0.000223	CcSEcCtD
Mefloquine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.91e-05	0.000222	CcSEcCtD
Mefloquine—Insomnia—Pregabalin—epilepsy syndrome	3.91e-05	0.000222	CcSEcCtD
Mefloquine—Nausea—Clonazepam—epilepsy syndrome	3.9e-05	0.000222	CcSEcCtD
Mefloquine—Headache—Carbamazepine—epilepsy syndrome	3.9e-05	0.000222	CcSEcCtD
Mefloquine—Shock—Gabapentin—epilepsy syndrome	3.9e-05	0.000222	CcSEcCtD
Mefloquine—Nervous system disorder—Gabapentin—epilepsy syndrome	3.89e-05	0.000221	CcSEcCtD
Mefloquine—Paraesthesia—Pregabalin—epilepsy syndrome	3.88e-05	0.000221	CcSEcCtD
Mefloquine—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.88e-05	0.000221	CcSEcCtD
Mefloquine—Nausea—Phenytoin—epilepsy syndrome	3.88e-05	0.00022	CcSEcCtD
Mefloquine—Tachycardia—Gabapentin—epilepsy syndrome	3.87e-05	0.00022	CcSEcCtD
Mefloquine—Dyspnoea—Pregabalin—epilepsy syndrome	3.86e-05	0.000219	CcSEcCtD
Mefloquine—Nausea—Oxcarbazepine—epilepsy syndrome	3.86e-05	0.000219	CcSEcCtD
Mefloquine—Vision blurred—Topiramate—epilepsy syndrome	3.85e-05	0.000219	CcSEcCtD
Mefloquine—Skin disorder—Gabapentin—epilepsy syndrome	3.85e-05	0.000219	CcSEcCtD
Mefloquine—Somnolence—Pregabalin—epilepsy syndrome	3.85e-05	0.000219	CcSEcCtD
Mefloquine—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.83e-05	0.000218	CcSEcCtD
Mefloquine—Tremor—Topiramate—epilepsy syndrome	3.83e-05	0.000218	CcSEcCtD
Mefloquine—Vomiting—Lamotrigine—epilepsy syndrome	3.83e-05	0.000218	CcSEcCtD
Mefloquine—Urticaria—Valproic Acid—epilepsy syndrome	3.8e-05	0.000216	CcSEcCtD
Mefloquine—Rash—Lamotrigine—epilepsy syndrome	3.8e-05	0.000216	CcSEcCtD
Mefloquine—Ill-defined disorder—Topiramate—epilepsy syndrome	3.79e-05	0.000216	CcSEcCtD
Mefloquine—Dermatitis—Lamotrigine—epilepsy syndrome	3.79e-05	0.000216	CcSEcCtD
Mefloquine—Abdominal pain—Valproic Acid—epilepsy syndrome	3.78e-05	0.000215	CcSEcCtD
Mefloquine—Body temperature increased—Valproic Acid—epilepsy syndrome	3.78e-05	0.000215	CcSEcCtD
Mefloquine—Headache—Lamotrigine—epilepsy syndrome	3.77e-05	0.000214	CcSEcCtD
Mefloquine—Decreased appetite—Pregabalin—epilepsy syndrome	3.76e-05	0.000214	CcSEcCtD
Mefloquine—Agitation—Topiramate—epilepsy syndrome	3.76e-05	0.000214	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.73e-05	0.000212	CcSEcCtD
Mefloquine—Fatigue—Pregabalin—epilepsy syndrome	3.73e-05	0.000212	CcSEcCtD
Mefloquine—Hypotension—Gabapentin—epilepsy syndrome	3.71e-05	0.000211	CcSEcCtD
Mefloquine—Nausea—Carbamazepine—epilepsy syndrome	3.7e-05	0.00021	CcSEcCtD
Mefloquine—Malaise—Topiramate—epilepsy syndrome	3.69e-05	0.00021	CcSEcCtD
Mefloquine—Vertigo—Topiramate—epilepsy syndrome	3.67e-05	0.000209	CcSEcCtD
Mefloquine—Syncope—Topiramate—epilepsy syndrome	3.67e-05	0.000208	CcSEcCtD
Mefloquine—Leukopenia—Topiramate—epilepsy syndrome	3.66e-05	0.000208	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.61e-05	0.000205	CcSEcCtD
Mefloquine—Palpitations—Topiramate—epilepsy syndrome	3.61e-05	0.000205	CcSEcCtD
Mefloquine—Loss of consciousness—Topiramate—epilepsy syndrome	3.59e-05	0.000204	CcSEcCtD
Mefloquine—Insomnia—Gabapentin—epilepsy syndrome	3.59e-05	0.000204	CcSEcCtD
Mefloquine—Nausea—Lamotrigine—epilepsy syndrome	3.58e-05	0.000203	CcSEcCtD
Mefloquine—Feeling abnormal—Pregabalin—epilepsy syndrome	3.56e-05	0.000203	CcSEcCtD
Mefloquine—Paraesthesia—Gabapentin—epilepsy syndrome	3.56e-05	0.000202	CcSEcCtD
Mefloquine—Convulsion—Topiramate—epilepsy syndrome	3.54e-05	0.000201	CcSEcCtD
Mefloquine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.54e-05	0.000201	CcSEcCtD
Mefloquine—Dyspnoea—Gabapentin—epilepsy syndrome	3.54e-05	0.000201	CcSEcCtD
Mefloquine—Hypertension—Topiramate—epilepsy syndrome	3.53e-05	0.000201	CcSEcCtD
Mefloquine—Somnolence—Gabapentin—epilepsy syndrome	3.53e-05	0.0002	CcSEcCtD
Mefloquine—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.52e-05	0.0002	CcSEcCtD
Mefloquine—Dyspepsia—Gabapentin—epilepsy syndrome	3.49e-05	0.000199	CcSEcCtD
Mefloquine—Chest pain—Topiramate—epilepsy syndrome	3.48e-05	0.000198	CcSEcCtD
Mefloquine—Arthralgia—Topiramate—epilepsy syndrome	3.48e-05	0.000198	CcSEcCtD
Mefloquine—Myalgia—Topiramate—epilepsy syndrome	3.48e-05	0.000198	CcSEcCtD
Mefloquine—Anxiety—Topiramate—epilepsy syndrome	3.47e-05	0.000197	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.46e-05	0.000197	CcSEcCtD
Mefloquine—Decreased appetite—Gabapentin—epilepsy syndrome	3.45e-05	0.000196	CcSEcCtD
Mefloquine—Discomfort—Topiramate—epilepsy syndrome	3.44e-05	0.000196	CcSEcCtD
Mefloquine—Urticaria—Pregabalin—epilepsy syndrome	3.44e-05	0.000195	CcSEcCtD
Mefloquine—Asthenia—Valproic Acid—epilepsy syndrome	3.43e-05	0.000195	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.42e-05	0.000195	CcSEcCtD
Mefloquine—Fatigue—Gabapentin—epilepsy syndrome	3.42e-05	0.000194	CcSEcCtD
Mefloquine—Abdominal pain—Pregabalin—epilepsy syndrome	3.42e-05	0.000194	CcSEcCtD
Mefloquine—Body temperature increased—Pregabalin—epilepsy syndrome	3.42e-05	0.000194	CcSEcCtD
Mefloquine—Pruritus—Valproic Acid—epilepsy syndrome	3.38e-05	0.000192	CcSEcCtD
Mefloquine—Confusional state—Topiramate—epilepsy syndrome	3.36e-05	0.000191	CcSEcCtD
Mefloquine—Oedema—Topiramate—epilepsy syndrome	3.34e-05	0.00019	CcSEcCtD
Mefloquine—Shock—Topiramate—epilepsy syndrome	3.28e-05	0.000187	CcSEcCtD
Mefloquine—Diarrhoea—Valproic Acid—epilepsy syndrome	3.27e-05	0.000186	CcSEcCtD
Mefloquine—Nervous system disorder—Topiramate—epilepsy syndrome	3.27e-05	0.000186	CcSEcCtD
Mefloquine—Feeling abnormal—Gabapentin—epilepsy syndrome	3.27e-05	0.000186	CcSEcCtD
Mefloquine—Thrombocytopenia—Topiramate—epilepsy syndrome	3.27e-05	0.000186	CcSEcCtD
Mefloquine—Tachycardia—Topiramate—epilepsy syndrome	3.26e-05	0.000185	CcSEcCtD
Mefloquine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.24e-05	0.000184	CcSEcCtD
Mefloquine—Skin disorder—Topiramate—epilepsy syndrome	3.24e-05	0.000184	CcSEcCtD
Mefloquine—Hyperhidrosis—Topiramate—epilepsy syndrome	3.23e-05	0.000183	CcSEcCtD
Mefloquine—Hypersensitivity—Pregabalin—epilepsy syndrome	3.19e-05	0.000181	CcSEcCtD
Mefloquine—Dizziness—Valproic Acid—epilepsy syndrome	3.16e-05	0.00018	CcSEcCtD
Mefloquine—Urticaria—Gabapentin—epilepsy syndrome	3.15e-05	0.000179	CcSEcCtD
Mefloquine—Abdominal pain—Gabapentin—epilepsy syndrome	3.14e-05	0.000178	CcSEcCtD
Mefloquine—Body temperature increased—Gabapentin—epilepsy syndrome	3.14e-05	0.000178	CcSEcCtD
Mefloquine—Hypotension—Topiramate—epilepsy syndrome	3.12e-05	0.000177	CcSEcCtD
Mefloquine—Asthenia—Pregabalin—epilepsy syndrome	3.1e-05	0.000176	CcSEcCtD
Mefloquine—Pruritus—Pregabalin—epilepsy syndrome	3.06e-05	0.000174	CcSEcCtD
Mefloquine—Vomiting—Valproic Acid—epilepsy syndrome	3.04e-05	0.000173	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.04e-05	0.000173	CcSEcCtD
Mefloquine—Insomnia—Topiramate—epilepsy syndrome	3.02e-05	0.000172	CcSEcCtD
Mefloquine—Rash—Valproic Acid—epilepsy syndrome	3.02e-05	0.000172	CcSEcCtD
Mefloquine—Dermatitis—Valproic Acid—epilepsy syndrome	3.01e-05	0.000171	CcSEcCtD
Mefloquine—Headache—Valproic Acid—epilepsy syndrome	3e-05	0.00017	CcSEcCtD
Mefloquine—Paraesthesia—Topiramate—epilepsy syndrome	3e-05	0.00017	CcSEcCtD
Mefloquine—Dyspnoea—Topiramate—epilepsy syndrome	2.97e-05	0.000169	CcSEcCtD
Mefloquine—Somnolence—Topiramate—epilepsy syndrome	2.97e-05	0.000169	CcSEcCtD
Mefloquine—Diarrhoea—Pregabalin—epilepsy syndrome	2.96e-05	0.000168	CcSEcCtD
Mefloquine—Dyspepsia—Topiramate—epilepsy syndrome	2.94e-05	0.000167	CcSEcCtD
Mefloquine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.92e-05	0.000166	CcSEcCtD
Mefloquine—Decreased appetite—Topiramate—epilepsy syndrome	2.9e-05	0.000165	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.88e-05	0.000164	CcSEcCtD
Mefloquine—Fatigue—Topiramate—epilepsy syndrome	2.88e-05	0.000164	CcSEcCtD
Mefloquine—Dizziness—Pregabalin—epilepsy syndrome	2.86e-05	0.000163	CcSEcCtD
Mefloquine—Asthenia—Gabapentin—epilepsy syndrome	2.85e-05	0.000162	CcSEcCtD
Mefloquine—Nausea—Valproic Acid—epilepsy syndrome	2.84e-05	0.000162	CcSEcCtD
Mefloquine—Pruritus—Gabapentin—epilepsy syndrome	2.81e-05	0.00016	CcSEcCtD
Mefloquine—Vomiting—Pregabalin—epilepsy syndrome	2.75e-05	0.000156	CcSEcCtD
Mefloquine—Feeling abnormal—Topiramate—epilepsy syndrome	2.75e-05	0.000156	CcSEcCtD
Mefloquine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.73e-05	0.000155	CcSEcCtD
Mefloquine—Rash—Pregabalin—epilepsy syndrome	2.73e-05	0.000155	CcSEcCtD
Mefloquine—Dermatitis—Pregabalin—epilepsy syndrome	2.72e-05	0.000155	CcSEcCtD
Mefloquine—Diarrhoea—Gabapentin—epilepsy syndrome	2.71e-05	0.000154	CcSEcCtD
Mefloquine—Headache—Pregabalin—epilepsy syndrome	2.71e-05	0.000154	CcSEcCtD
Mefloquine—Urticaria—Topiramate—epilepsy syndrome	2.65e-05	0.000151	CcSEcCtD
Mefloquine—Body temperature increased—Topiramate—epilepsy syndrome	2.64e-05	0.00015	CcSEcCtD
Mefloquine—Abdominal pain—Topiramate—epilepsy syndrome	2.64e-05	0.00015	CcSEcCtD
Mefloquine—Dizziness—Gabapentin—epilepsy syndrome	2.62e-05	0.000149	CcSEcCtD
Mefloquine—Nausea—Pregabalin—epilepsy syndrome	2.57e-05	0.000146	CcSEcCtD
Mefloquine—Vomiting—Gabapentin—epilepsy syndrome	2.52e-05	0.000143	CcSEcCtD
Mefloquine—Rash—Gabapentin—epilepsy syndrome	2.5e-05	0.000142	CcSEcCtD
Mefloquine—Dermatitis—Gabapentin—epilepsy syndrome	2.5e-05	0.000142	CcSEcCtD
Mefloquine—Headache—Gabapentin—epilepsy syndrome	2.48e-05	0.000141	CcSEcCtD
Mefloquine—Hypersensitivity—Topiramate—epilepsy syndrome	2.46e-05	0.00014	CcSEcCtD
Mefloquine—Asthenia—Topiramate—epilepsy syndrome	2.39e-05	0.000136	CcSEcCtD
Mefloquine—Pruritus—Topiramate—epilepsy syndrome	2.36e-05	0.000134	CcSEcCtD
Mefloquine—Nausea—Gabapentin—epilepsy syndrome	2.36e-05	0.000134	CcSEcCtD
Mefloquine—Diarrhoea—Topiramate—epilepsy syndrome	2.28e-05	0.00013	CcSEcCtD
Mefloquine—Dizziness—Topiramate—epilepsy syndrome	2.21e-05	0.000125	CcSEcCtD
Mefloquine—Vomiting—Topiramate—epilepsy syndrome	2.12e-05	0.000121	CcSEcCtD
Mefloquine—Rash—Topiramate—epilepsy syndrome	2.1e-05	0.00012	CcSEcCtD
Mefloquine—Dermatitis—Topiramate—epilepsy syndrome	2.1e-05	0.00012	CcSEcCtD
Mefloquine—Headache—Topiramate—epilepsy syndrome	2.09e-05	0.000119	CcSEcCtD
Mefloquine—Nausea—Topiramate—epilepsy syndrome	1.98e-05	0.000113	CcSEcCtD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.02e-06	5.83e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FYN—epilepsy syndrome	6e-06	5.81e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	6e-06	5.81e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR7—epilepsy syndrome	5.98e-06	5.8e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—H2AFX—epilepsy syndrome	5.98e-06	5.79e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	5.97e-06	5.78e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MEF2C—epilepsy syndrome	5.97e-06	5.78e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	5.92e-06	5.73e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	5.92e-06	5.73e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	5.92e-06	5.73e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	5.92e-06	5.73e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	5.92e-06	5.73e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ADK—epilepsy syndrome	5.92e-06	5.73e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—SLC2A1—epilepsy syndrome	5.9e-06	5.72e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.84e-06	5.66e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PLCB1—epilepsy syndrome	5.84e-06	5.66e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	5.83e-06	5.65e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	5.83e-06	5.65e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP2D6—epilepsy syndrome	5.82e-06	5.64e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ASAH1—epilepsy syndrome	5.82e-06	5.64e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TH—epilepsy syndrome	5.82e-06	5.64e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HBEGF—epilepsy syndrome	5.81e-06	5.63e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.77e-06	5.59e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.75e-06	5.57e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.73e-06	5.55e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	5.71e-06	5.53e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT3—epilepsy syndrome	5.7e-06	5.53e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NGF—epilepsy syndrome	5.7e-06	5.53e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—BCHE—epilepsy syndrome	5.69e-06	5.51e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—POMC—epilepsy syndrome	5.67e-06	5.49e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—STXBP1—epilepsy syndrome	5.66e-06	5.48e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ADAM10—epilepsy syndrome	5.57e-06	5.4e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR5—epilepsy syndrome	5.55e-06	5.38e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL2—epilepsy syndrome	5.54e-06	5.37e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ADRA2A—epilepsy syndrome	5.54e-06	5.37e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	5.54e-06	5.37e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	5.53e-06	5.36e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NT5E—epilepsy syndrome	5.51e-06	5.34e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALAD—epilepsy syndrome	5.51e-06	5.34e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.49e-06	5.32e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	5.48e-06	5.31e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR2A—epilepsy syndrome	5.43e-06	5.26e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	5.42e-06	5.26e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	5.42e-06	5.25e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	5.41e-06	5.24e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	5.41e-06	5.24e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	5.41e-06	5.24e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	5.41e-06	5.24e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	5.38e-06	5.22e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	5.36e-06	5.2e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TH—epilepsy syndrome	5.35e-06	5.18e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	5.33e-06	5.17e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—S100B—epilepsy syndrome	5.27e-06	5.1e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SLC2A1—epilepsy syndrome	5.27e-06	5.1e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.26e-06	5.1e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	5.26e-06	5.1e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	5.26e-06	5.1e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SOCS3—epilepsy syndrome	5.22e-06	5.05e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PLCB1—epilepsy syndrome	5.21e-06	5.05e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDC42—epilepsy syndrome	5.2e-06	5.04e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	5.2e-06	5.04e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	5.2e-06	5.04e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TH—epilepsy syndrome	5.19e-06	5.03e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TSC2—epilepsy syndrome	5.16e-06	5e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AGT—epilepsy syndrome	5.15e-06	4.99e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	5.15e-06	4.99e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.11e-06	4.95e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APOE—epilepsy syndrome	5.05e-06	4.89e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ADSL—epilepsy syndrome	5.04e-06	4.89e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AVP—epilepsy syndrome	5.04e-06	4.88e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CA4—epilepsy syndrome	5.03e-06	4.87e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	5.03e-06	4.87e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	5.01e-06	4.86e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	4.96e-06	4.8e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	4.96e-06	4.8e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GLUL—epilepsy syndrome	4.95e-06	4.79e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KDR—epilepsy syndrome	4.94e-06	4.79e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	4.85e-06	4.7e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—HMOX1—epilepsy syndrome	4.85e-06	4.7e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	4.85e-06	4.7e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	4.83e-06	4.68e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CAT—epilepsy syndrome	4.79e-06	4.64e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HES1—epilepsy syndrome	4.76e-06	4.62e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PRKCB—epilepsy syndrome	4.76e-06	4.61e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	4.75e-06	4.61e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6ST—epilepsy syndrome	4.74e-06	4.59e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.73e-06	4.58e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.7e-06	4.56e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	4.66e-06	4.52e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ABCB1—epilepsy syndrome	4.66e-06	4.52e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FYN—epilepsy syndrome	4.63e-06	4.49e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—H2AFX—epilepsy syndrome	4.62e-06	4.47e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MEF2C—epilepsy syndrome	4.61e-06	4.46e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	4.58e-06	4.43e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4.54e-06	4.4e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.51e-06	4.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.48e-06	4.34e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.48e-06	4.34e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.48e-06	4.34e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.48e-06	4.34e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.48e-06	4.34e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.47e-06	4.33e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	4.46e-06	4.32e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	4.45e-06	4.32e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AQP1—epilepsy syndrome	4.41e-06	4.27e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NGF—epilepsy syndrome	4.4e-06	4.27e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CAT—epilepsy syndrome	4.4e-06	4.27e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—POMC—epilepsy syndrome	4.34e-06	4.2e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GPX1—epilepsy syndrome	4.33e-06	4.2e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—HMOX1—epilepsy syndrome	4.33e-06	4.2e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR5—epilepsy syndrome	4.28e-06	4.15e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	4.28e-06	4.15e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	4.28e-06	4.15e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CAT—epilepsy syndrome	4.27e-06	4.14e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL2—epilepsy syndrome	4.24e-06	4.11e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR2A—epilepsy syndrome	4.19e-06	4.06e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ABCB1—epilepsy syndrome	4.16e-06	4.03e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	4.15e-06	4.03e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.1e-06	3.97e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.1e-06	3.97e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.1e-06	3.97e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.03e-06	3.91e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.99e-06	3.86e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.99e-06	3.86e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TSC2—epilepsy syndrome	3.98e-06	3.86e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GPX1—epilepsy syndrome	3.98e-06	3.86e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AGT—epilepsy syndrome	3.98e-06	3.85e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.95e-06	3.82e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APOE—epilepsy syndrome	3.9e-06	3.78e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GPX1—epilepsy syndrome	3.86e-06	3.75e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGF2—epilepsy syndrome	3.83e-06	3.72e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KDR—epilepsy syndrome	3.82e-06	3.7e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.81e-06	3.69e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.81e-06	3.69e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AGT—epilepsy syndrome	3.8e-06	3.68e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.76e-06	3.64e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.76e-06	3.64e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOE—epilepsy syndrome	3.72e-06	3.61e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PRKCB—epilepsy syndrome	3.67e-06	3.56e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6ST—epilepsy syndrome	3.66e-06	3.55e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.58e-06	3.47e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RELA—epilepsy syndrome	3.56e-06	3.45e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AGT—epilepsy syndrome	3.49e-06	3.38e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MTOR—epilepsy syndrome	3.49e-06	3.38e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.49e-06	3.38e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOE—epilepsy syndrome	3.42e-06	3.31e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.4e-06	3.29e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.4e-06	3.29e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AGT—epilepsy syndrome	3.39e-06	3.28e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—POMC—epilepsy syndrome	3.35e-06	3.24e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOE—epilepsy syndrome	3.32e-06	3.22e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL2—epilepsy syndrome	3.28e-06	3.17e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.25e-06	3.15e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.24e-06	3.14e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.24e-06	3.14e-05	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.24e-06	3.14e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—epilepsy syndrome	3.21e-06	3.11e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—POMC—epilepsy syndrome	3.2e-06	3.1e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.17e-06	3.07e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.17e-06	3.07e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.15e-06	3.05e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—JUN—epilepsy syndrome	3.12e-06	3.02e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.11e-06	3.01e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.06e-06	2.97e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.05e-06	2.95e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—epilepsy syndrome	3.03e-06	2.94e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3e-06	2.91e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.99e-06	2.9e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.98e-06	2.89e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.97e-06	2.87e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGF2—epilepsy syndrome	2.96e-06	2.87e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AKT1—epilepsy syndrome	2.94e-06	2.85e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—POMC—epilepsy syndrome	2.94e-06	2.85e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—epilepsy syndrome	2.92e-06	2.83e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—POMC—epilepsy syndrome	2.85e-06	2.76e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.84e-06	2.75e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.8e-06	2.71e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SRC—epilepsy syndrome	2.8e-06	2.71e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RELA—epilepsy syndrome	2.75e-06	2.66e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—epilepsy syndrome	2.72e-06	2.64e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.72e-06	2.63e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.71e-06	2.63e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.7e-06	2.62e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MTOR—epilepsy syndrome	2.69e-06	2.61e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.69e-06	2.61e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—epilepsy syndrome	2.68e-06	2.6e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—epilepsy syndrome	2.6e-06	2.52e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.57e-06	2.49e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—epilepsy syndrome	2.55e-06	2.47e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.55e-06	2.47e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.54e-06	2.46e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.54e-06	2.46e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TH—epilepsy syndrome	2.53e-06	2.45e-05	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.5e-06	2.42e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—epilepsy syndrome	2.48e-06	2.4e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.46e-06	2.38e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.46e-06	2.38e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.42e-06	2.35e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—JUN—epilepsy syndrome	2.41e-06	2.33e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.39e-06	2.32e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TH—epilepsy syndrome	2.39e-06	2.31e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	2.34e-06	2.27e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.34e-06	2.27e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—epilepsy syndrome	2.28e-06	2.2e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.27e-06	2.2e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SRC—epilepsy syndrome	2.16e-06	2.09e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.11e-06	2.05e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.1e-06	2.04e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CAT—epilepsy syndrome	2.09e-06	2.02e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2e-06	1.94e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.99e-06	1.93e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.96e-06	1.9e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.95e-06	1.89e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.94e-06	1.88e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.91e-06	1.85e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.89e-06	1.83e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.78e-06	1.72e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.75e-06	1.7e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT1—epilepsy syndrome	1.74e-06	1.68e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.67e-06	1.61e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.66e-06	1.61e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AGT—epilepsy syndrome	1.65e-06	1.6e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOE—epilepsy syndrome	1.62e-06	1.57e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.58e-06	1.53e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.57e-06	1.52e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.56e-06	1.51e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.56e-06	1.51e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.53e-06	1.48e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—POMC—epilepsy syndrome	1.39e-06	1.35e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.34e-06	1.3e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.31e-06	1.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.3e-06	1.26e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.28e-06	1.24e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKT1—epilepsy syndrome	1.28e-06	1.24e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—epilepsy syndrome	1.27e-06	1.23e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.25e-06	1.21e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.2e-06	1.16e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKT1—epilepsy syndrome	1.18e-06	1.14e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.16e-06	1.13e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKT1—epilepsy syndrome	1.14e-06	1.11e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.11e-06	1.08e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.05e-06	1.01e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.02e-06	9.87e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.98e-07	9.67e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.57e-07	8.31e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.82e-07	7.58e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.84e-07	6.63e-06	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.58e-07	5.41e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.26e-07	5.1e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.44e-07	3.33e-06	CbGpPWpGaD
